|Articles|October 1, 2018
- Pharmaceutical Executive-10-01-2018
- Volume 38
- Issue 10
Pharmaceutical Executive, October 2018 Issue (PDF)
Click the title above to open the Pharmaceutical October 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 7 years ago
Pharm Exec's Emerging Pharma Leaders 2018over 7 years ago
Choosing the Right Track: Pharma & Healthcare MBAsover 7 years ago
Getting Where You Need to Goover 7 years ago
Vienna’s Vision on Health Regulation in Europeover 7 years ago
FDA Launches Major Push for New Antimicrobialsover 7 years ago
Medical Affairs’ Search for MeaningAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly’s Foundayo and Lower-Dose Zepbound Helped Maintain Weight Loss in Patients Switching from Injectables
2
Beyond the Molecule: The New Competitive Battlefield in Oncology
3
FDA Approves Beqalzi for Relapsed or Refractory Mantle Cell Lymphoma, Inqovi in Combination with Venetoclax
4
Pharmaceutical Executive Daily: Rigel Pharmaceuticals Enters an Exclusive Global Licensing Agreement with Arvinas and Pfizer for Veppanu
5